Silo Pharma, Inc. Quarterly Debt-to-equity in % from Q3 2013 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Silo Pharma, Inc. quarterly Debt-to-equity history and growth rate from Q3 2013 to Q4 2024.
  • Silo Pharma, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 34.2 %, a 63.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 34.2 +13.2 +63.1% Dec 31, 2024
Q3 2024 29.3 +11.5 +64.7% Sep 30, 2024
Q2 2024 27.2 +12.2 +80.5% Jun 30, 2024
Q1 2024 24.4 +11.1 +83.9% Mar 31, 2024
Q4 2023 21 +8.32 +65.7% Dec 31, 2023
Q3 2023 17.8 +4.35 +32.4% Sep 30, 2023
Q2 2023 15.1 +0.9 +6.34% Jun 30, 2023
Q1 2023 13.3 -2.97 -18.3% Mar 31, 2023
Q4 2022 12.7 -6.38 -33.5% Dec 31, 2022
Q3 2022 13.4 -6.63 -33.1% Sep 30, 2022
Q2 2022 14.2 -10.4 -42.3% Jun 30, 2022
Q1 2022 16.3 -0.38 -2.28% Mar 31, 2022
Q4 2021 19 Dec 31, 2021
Q3 2021 20.1 Sep 30, 2021
Q2 2021 24.6 Jun 30, 2021
Q1 2021 16.6 Mar 31, 2021
Q4 2013 31.4 Dec 31, 2013
Q3 2013 107 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.